$LUNG stock has now risen 39% today, according to our price data from Polygon. There has been approximately $49,033,041 of trading volume.
Here is what we see in our data on $LUNG (you can track the company live on Quiver's $LUNG stock page):$LUNG Insider Trading Activity
$LUNG insiders have traded $LUNG stock on the open market 28 times in the past 6 months. Of those trades, 1 have been purchases and 27 have been sales.
Here’s a breakdown of recent trading of $LUNG stock by insiders over the last 6 months:
- DANIEL P FLORIN purchased 23,321 shares for an estimated $71,362
- DAVID AARON LEHMAN (GENERAL COUNSEL) has made 0 purchases and 9 sales selling 20,226 shares for an estimated $48,366.
- STEVEN S. WILLIAMSON (PRESIDENT AND CEO) has made 0 purchases and 4 sales selling 19,571 shares for an estimated $46,495.
- MEHUL JOSHI (Chief Financial Officer & PAO) has made 0 purchases and 4 sales selling 15,997 shares for an estimated $37,928.
- GEOFFREY BERAN ROSE (CHIEF COMMERCIAL OFFICER) has made 0 purchases and 9 sales selling 13,490 shares for an estimated $32,216.
- RICHARD FERRARI sold 8,000 shares for an estimated $25,280
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$LUNG Hedge Fund Activity
We have seen 56 institutional investors add shares of $LUNG stock to their portfolio, and 62 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- DEERFIELD MANAGEMENT COMPANY, L.P. removed 1,575,901 shares (-45.5%) from their portfolio in Q2 2025, for an estimated $4,081,583
- FMR LLC removed 1,156,888 shares (-21.4%) from their portfolio in Q2 2025, for an estimated $2,996,339
- MILLENNIUM MANAGEMENT LLC added 958,048 shares (+459.5%) to their portfolio in Q2 2025, for an estimated $2,481,344
- GSA CAPITAL PARTNERS LLP added 423,725 shares (+inf%) to their portfolio in Q2 2025, for an estimated $1,097,447
- BANK OF AMERICA CORP /DE/ added 407,971 shares (+556.6%) to their portfolio in Q2 2025, for an estimated $1,056,644
- FRANKLIN RESOURCES INC removed 357,936 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $927,054
- ESSEX INVESTMENT MANAGEMENT CO LLC removed 303,246 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $785,407
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$LUNG Government Contracts
We have seen $292,066 of award payments to $LUNG over the last year.
Here are some of the awards which we have have seen pay out the most over the last year:
- PROSTHETICS:IMPLANT: $24,800
- ZEPHR VALVES: $22,414
- PROSTHETICS PULMONARY SURGICAL IMPLANTS: $22,320
- CUSTOM SURGICAL IMPLANTS: $17,940
- ENDOBRONCHIAL VALVE: $17,940
To track government contracts to publicy traded companies, check out Quiver Quantitative's government contracts dashboard.
$LUNG Analyst Ratings
Wall Street analysts have issued reports on $LUNG in the last several months. We have seen 3 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- D. Boral Capital issued a "Buy" rating on 10/28/2025
- Lake Street issued a "Buy" rating on 07/31/2025
- Stifel issued a "Buy" rating on 07/31/2025
To track analyst ratings and price targets for $LUNG, check out Quiver Quantitative's $LUNG forecast page.
$LUNG Price Targets
Multiple analysts have issued price targets for $LUNG recently. We have seen 6 analysts offer price targets for $LUNG in the last 6 months, with a median target of $4.575.
Here are some recent targets:
- Jason Kolbert from D. Boral Capital set a target price of $14.0 on 10/28/2025
- Larry Biegelsen from Wells Fargo set a target price of $3.0 on 08/01/2025
- Frank Takkinen from Lake Street set a target price of $8.0 on 07/31/2025
- Rick Wise from Stifel set a target price of $5.0 on 07/31/2025
- Jason Bednar from Piper Sandler set a target price of $2.5 on 07/31/2025
- Joanne Wuensch from Citigroup set a target price of $4.15 on 05/22/2025
You can track data on $LUNG on Quiver Quantitative.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
